共 50 条
- [41] A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once-Weekly DPP-4 Inhibitor, Does Not Prolong the QTc Interval CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (05): : 383 - 392
- [48] Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study Diabetes Therapy, 2020, 11 : 133 - 145